Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer
Cellular apoptosis susceptibility (chromosome segregation 1‐like, CSE1L) gene maps to chromosomal region 20q13.13, a region frequently amplified in solid tumours. In this study, we investigated the roles played by CSE1L in colorectal cancer by examining CSE1L expression and clinico‐pathological para...
Saved in:
Published in | The Journal of pathology Vol. 228; no. 4; pp. 471 - 481 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.12.2012
Wiley Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cellular apoptosis susceptibility (chromosome segregation 1‐like, CSE1L) gene maps to chromosomal region 20q13.13, a region frequently amplified in solid tumours. In this study, we investigated the roles played by CSE1L in colorectal cancer by examining CSE1L expression and clinico‐pathological parameters in colorectal cancer and investigating the effect of CSE1L on the viability, adhesion and migration of colorectal cancer cells. RT‐PCR showed that CSE1L mRNA was over‐expressed in colorectal cancer. CSE1L depletion by knock‐down with CSE1L‐specific siRNA significantly reduced viability in HCT116 cells (p = 0.004) and SW480 cells (p = 0.003) whilst significantly increasing the proportion of apoptotic HCT116 cells (p < 0.001) and SW480 cells (p < 0.001). Furthermore, CSE1L depletion significantly reduced the adhesive capacity of HCT116 (p = 0.003) and SW480 cells (p = 0.004). Analysis by qRT‐PCR following CSE1L siRNA treatment of HCT116 and SW480 cells showed significant modulation of key apoptotic (p53, p73 and BAK) and adhesive (E‐cadherin, Ep‐CAM and ICAM‐1) molecules. Immunohistochemistry of a colorectal cancer tissue microarray showed that CSE1L had a significantly increased level in colorectal cancer compared to normal colorectal epithelium (p < 0.001). There were significant decreases in both nuclear (p = 0.006) and cytoplasmic (p = 0.003) staining of CSE1L in tumours with lymph node metastasis (stage 3 tumours) compared with lymph node‐negative tumours (stage 1 and 2 tumours). In lymph node‐negative patients, poor survival was associated with increased CSE1L cytoplasmic expression (p = 0.042). These results indicate that CSE1L is associated with viability and apoptosis, cellular adhesion and invasion, thus implicating CSE1L in the progression of colorectal cancer. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
---|---|
Bibliography: | Supporting Information: Supplementary materials and methodsSupporting Information: Figure S1. Relationship of CSE1L, p53 and survival in colorectal cancer.Supporting Information: Table S1. Primers sequences, size of PCR products and PCR conditions for semi-quantitative RT-PCR.Supporting Information: Table S2. Primer sequences, size of products and PCR conditions for quantitative RT-PCR.Supporting Information: Table S3. Summary of siRNA sequences, target position and the percentage GC content.Supporting Information: Table S4. Comparison of CSE1L and p53 in primary colorectal cancer.Supporting Information: Table S5. Relationship of CSE1L and MSI status in colorectal cancer. ark:/67375/WNG-1P48JQBN-C istex:8CDA4E486A2DE13C9C8B5DCC31B2AEF781F7F25A ArticleID:PATH4031 Conflict of interest: Ayham Alnabulsi and Steve Bird each hold shares in Vertebrate Antibodies Ltd, which had no input into the current study. All the other authors have no conflict of interest. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-3417 1096-9896 |
DOI: | 10.1002/path.4031 |